Large-Joint Reconstructive Implants – Market Insights – Asia Pacific

The Asia Pacific large-joint reconstructive implant market has experienced limited growth in the initial years due to COVID-19 considering many hip and knee implant procedures are considered elective; however, the market continues to recover, with growth owing to the rising aging population, adoption of innovative devices, and growing demand for advanced technologies such as AI and robotics for enhanced patient outcome. Budgetary constraints among many Asia Pacific facilities will nonetheless result in slower adoption of premium-priced technologies that will hinder revenue potential to some degree.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for large-joint reconstructive implants in the Asia Pacific region from 2019 through 2032.

Nationwide implementation of volume-based procurement program has impacted the large-joint reconstructive implant market in China.

How will volume-based procurement program impact the large-joint reconstructive implant sales, ASPs, and revenues in China?

What strategies are being adopted to by market players to remain successful under the volume-based procurement program?

Technological advancement in the space of 3-D printed implants and robotic technologies is somewhat hindered by cost constraints in the Asia Pacific region. 

What has been the impact of budgetary limitation on the product mix in the Asia Pacific countries?

Despite cost constraints, what factors will drive the adoption of technological innovation in the Asia Pacific?

Impact of registry data on the adoption of various large-joint reconstructive implant products?

Table of contents